Cliff Asness’s scPharmaceuticals SCPH Stock Holding History

Cliff Asness’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,567	Closed	-$76.9K	–	3634
2025 Q3	$76.9K	Buy	13,567 +3,076	+29%	+$15.8K	﹤0.01%	3393
2025 Q2	$40K	Buy	+10,491	New	+$32.6K	﹤0.01%	3250
2024 Q1	–	Sell	-10,244	Closed	-$64.2K	–	2493
2023 Q4	$64.2K	Sell	10,244 -600	-6%	-$3.44K	﹤0.01%	2297
2023 Q3	$77.2K	Buy	+10,844	New	+$85.4K	﹤0.01%	2256

Cliff Asness's SCPH Position: Q4 2025 in Review

Cliff Asness sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 13,567 shares — an estimated $76.9K sold.

Cliff Asness first reported a position in SCPH in Q3 2023 and held it in 4 quarters. The position peaked at $77.2K in Q3 2023. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Cliff Asness reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Cliff Asness sold 13,567 scPharmaceuticals shares in Q4 2025, an estimated $76.9K.
Cliff Asness first reported a position in scPharmaceuticals in Q3 2023 and held it in 4 quarters.
Cliff Asness's scPharmaceuticals position peaked at $77.2K in Q3 2023.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on AQR Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.